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Summary The effects of expressing neu-T, a mutated constitutively activated form of c-neu, have been
examined in the non-transformed conditionally immortalised human mammary luminal epithelial cell line,
HB4a. A variant cell line, N4.1, which expressed neu-T, showed evidence of transformation, including partial
loss of growth factor dependence and acquisition of anchorage-independent growth, but failed to give rise to
tumours in nude mice, indicating that expression ofneu-T alone was probably insufficient to cause tumorigenic
progression to a full malignant phenotype. During characterisation of the N4.1 cell line, it was observed that
under conditions of serum deprivation, it underwent apoptotic cell death, as demonstrated by light micros-
copy, flow cytometry and DNA gel electrophoresis. The induction of apoptotic cell death in the N4.1 cell line
by serum deprivation was abrogated specifically by the addition of steroids with glucocorticoid activity but not
any peptide growth factors studied. This study shows the induction of apoptosis by serum deprivation, and its
abrogation by glucocorticoids occurring in human mammary luminal epithelial cells transformed by expression
of neu-T, and implicates the involvement of receptor protein tyrosine kinases in an apoptotic signalling
pathway in this cell type.
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c-erbB-2 is a member of a gene family encoding membrane-
spanning receptor protein tyrosine kinases (Yamamoto et al.,
1986; Ullrich and Schlessinger, 1990) and consists of three
major structural domains: the extracellular ligand-binding
domain, the transmembrane domain and the intracellular
kinase domain. Overexpression of c-erbB-2 has been reported
in 25-30% of human breast cancers and is associated with
both a poor response to therapy and an overall reduced
survival rate (Gullick et al., 1991; Gusterson et al., 1992).
The overexpression of c-erbB-2 is thought to lead to dimer-
isation of the receptor, resulting in its constitutive autophos-
phorylation and activation of the protein tyrosine kinase
domain. In addition to overexpression, an alternative means
of activation of the protein tyrosine kinase domain has been
reported for c-neu, the rat homologue ofc-erbB-2. A mutated
form of c-neu, referred to here as neu-T, isolated from
chemically induced neuro- and glioblastomas, has been found
to contain a single, specific point mutation in the transmemb-
rane domain that results in the constitutive activation of the
protein tyrosine kinase domain (Schechter et al., 1984).
Overexpression of c-erbB-2, or expression of neu-T, is
sufficient to transform the NIH 3T3 mouse fibroblast cell line
(DiFiore et al., 1987; Hudziak et al., 1987). Expression of
neu-T in vivo can give rise to tumours in transgenic mice.
However, there are conflicting reports as to whether the
presence of neu-T is sufficient or merely necessary for the
development of malignancy in these models (Muller et al.,
1988; Bouchard et al., 1989). Few investigations have been
performed on human mammary luminal epithelial cells,
which are the site of origin of the majority of human breast
cancers, but these have suggested that when c-erbB-2 is
overexpressed to high levels, tumorigenic transformation can
result (Pierce et al., 1991).
In the present work, the mutated constitutively active neu-
T was introduced into the conditionally immortalised human
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mammary luminal epithelial cell line, HB4a (Stamps et al.,
1994), to evaluate the transforming potential of the gene.
During the characterisation of the variant cell lines produced,
it was observed that, under certain conditions, expression of
neu-T can also lead to the induction of apoptosis, and that
this can be abrogated by glucocorticoid hormones.
Materials and methods
Chemicals and reagents
RPMI-1640 cell culture medium and the antibiotics penicillin
and streptomycin were purchased from ICN Flow (High
Wycombe, Bucks, UK), fetal calf serum from Bioclear
(Devizes, Wiltshire, UK), Transfectam reagent from Promega
(Chilworth, Southampton, UK), Nucleon DNA extraction
kit from Scotlab (Coatbridge, Strathclyde, U.K.), EcoRI and
XbaI restriction endonucleases from Gibco Life Technologies
(Paisley, Renfrewshire, U.K.), 'Quik-hyb' solution and
'Prime-it' kit from Stratagene (Cambridge Science Park,
Cambridge, UK), c-neu Ab-3 and c-neu Ab-4 antibodies from
Oncogene Science (Stourbridge Common, Cambridge, UK),
RC20 antibody from Transduction Laboratories (Affiniti,
GPT Business Park, Nottingham, UK), streptavidin fluo-
rescein protein and ECL chemiluminescence system from
Amersham Life Science (Little Chalfont, Buckinghamshire,
UK), Immobilon-P transfer membrane from Millipore (Bed-
ford, MA. USA), Noble agar from Difco Laboratories
(Detroit, MI, USA), Matrigel from Collaborative Biomedical
Products (Bedford, MA, USA) and Epon-Araldite (Agar
Scientific) and all other reagents from Sigma (Poole, Dorset,
UK).
Cell culture and isolation ofvariant cell lines
The derivation of the HB4a cell line using an amphotrophic
retroviral vector to transduce the tsA58-U19 recombinant
mutant SV40 large T antigen gene into FAC-sorted normal
human mammary luminal epithelial cells has been described
previously (Stamps et al., 1994). Cells were routinely culturedat 37C in phenol red-containing RPMI-1640 medium supple-
mented with 10% (v/v) fetal calf serum (FCS), 5 gg ml-'
hydrocortisone, 5tLgml-' insulin and lOOngmlhl cholera
toxin plus penicillin and streptomycin (complete medium) as
described for the establishment and clonal growth of normal
human mammary cells (O'Hare et al., 1991). The DNA
expression construct pSV2neu-T contains a cDNA corre-
sponding to the full-length mutated rat neu-T sequence,
under the control of the SV40 early promoter. Transfection
of plasmids into the HB4a cell line at passage 30 after
establishment was performed using the lipid-based reagent,
Transfectam, according to the manufacturer's instructions.
For selection purposes, pSV2neu-T was co-transfected with
the drug selection plasmid pSV2hyg, which contains the
hygromycin B resistance sequence, in a 5:1 ratio, since the
HB4a cell line already carries the neomycin resistance gene.
Control cultures were transfected with pSV2hyg only. Trans-
fected cells were allowed to grow for 1 week in complete
growth medium before drug selection (50jg ml-' hyg-
romycin B). After 3-4 weeks individual colonies were
isolated by ring cloning and expanded.
Molecular characterisation ofneu-T-expressing cell lines
Ten micrograms of genomic DNA was prepared from neu-T-
expressing cell lines using the Nucleon kit and digested with
EcoRI and XbaI. Southern blotting was performed on the
digested DNA (Sambrook et al., 1989) and the blots were
hybridised with a 32P-labelled, random primed, c-neu cDNA
probe (labelled with the 'Prime-it' kit), and hybridised in
'Quik-hyb' solution. Total RNA was prepared from cell lines
using guanidinium thiocyanate (Chomczynski and Sacchi,
1987). Northern blotting was carried out on 10ytg of this
RNA (Sambrook et al., 1989) and blots were hybridised to a
radiolabelled c-neu probe.
Immunochemicals, immunoblotting and immunoprecipitation
Immunoblotting for c-neu used the mouse monoclonal
antibody, c-neu Ab-3, which recognises both the rat protein
and c-erbB-2. Immunoblotting for anti-phosphotyrosine was
achieved with the recombinant anti-phosphotyrosine peroxi-
dase-conjugated antibody, RC20. The mouse monoclonal
antibody c-neu Ab-4, raised to the external domain of the rat
c-neu gene product, ivas used for immunoprecipitation
studies. Indirect immunofluorescence detected binding of c-
neu Ab-4 using a goat anti-mouse IgG (whole molecule)
biotin-conjugated antibody followed by streptavidin fluo-
rescein protein. For FACS analysis c-neu Ab-4 was visualised
with a goat anti-mouse IgG (Fc specific) FITC-conjugated
antibody on freshly trypsinised live cells after staining on ice.
For immunoprecipitation, 1-2 x 106 cells were washed
with phosphate-buffered saline (PBS) containing 1 mM
sodium orthovanadate and lysed in lysis buffer (10 mM
disodium hydrogen phosphate, 10 mM sodium dihydrogen
phosphate, 150 mM sodium chloride, 1% (v/v) Nonidet P-40,
10% (v/v) glycerol, 50 mM sodium fluoride, 10 mM sodium
pyrophosphate, protease inhibitors (40 iLM leupeptin, 10 g
ml-' aprotinin and 1 mM phenylmethylsulphonyl fluoride)
and tyrosine phosphatase inhibitors (1 mm sodium
orthovanadate and 10 mM benzamidine hydrochloride)).
Approximately 250fLg of total protein lysate was mixed, by
rotation, with 1-2 tLg of antibody, at 4'C for 1 h. Antibody-
bound protein was captured by rotation with 50 of protein
A-Sepharose CL-4B beads (10 mg ml-' in lysis buffer), at
4°C, for 2-3 h. Beads were pelleted by centrifugation at
11 000 r.p.m. for 5 min at 4'C, and washed five times in lysis
buffer before being prepared for SDS-PAGE (Harlow and
Lane, 1988). After SDS- PAGE, proteins were transferred to
Immobilon-P transfer membrane by conventional wet blot-
ting technique (Harlow and Lane, 1988). Detection of neu-T
and phosphotyrosine was performed using the ECL
chemiluminescence system according to manufacturer's ins-
tructions.
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Growth assays
Replicates of 1 x 105 cells were allowed to attach overnight
to 25 cm2 culture flasks in RPMI-1640 containing 10% (v/v)
fetal calf serum (basal medium). The following day the cells
were washed with PBS and then re-fed with RPMI-1640
medium, containing various additives. For single-point
growth measurements, cells were set up in quadruplicate,
harvested after 7 days and counted using a haemocytometer.
For multipoint growth curves, cells were set up in triplicate,
harvested at daily intervals, and counted as above. For multi-
well growth experiments cells were set up at 2 or 5 x 104 cells
per well in 24-well culture plates, in triplicate, overnight in
basal medium. The following day cells were washed with
PBS, and re-fed with RPMI-1640 containing additives
specified. Results were obtained by staining cells with
methylene blue [0.5% (w/v) in 50% ethanol] for 2 h, followed
by rinsing in water to remove excess stain. Staining was
quantified spectrophotometrically by solubilising with lauryl
sarkosyl [1% (v/v) in PBS] and measuring the absorbance at
620 nm.
Assays oftumorigenicity
Cell lines were assayed for the acquisition of anchorage-
independent growth using Noble agar [0.3% (w/v) in com-
plete medium] as described by Freshney (1983). They were
assayed for tumorigenicity in vivo by inoculating them sub-
cutaneously into both nude and severe combined
immunodeficient (SCID) mice at 1 x 106 cells per site as
described by Topley et al. (1993) either with or without
basement membrane extract (Matrigel) as a vehicle.
Analysis ofapoptosis
Cells which had detached into the growth medium were
harvested by centrifugation at 1800 r.p.m. for 5 min at room
temperature. The resulting cell pellets were prepared as for
electron microscopy by fixation with 2.5% (v/v) glutaral-
dehyde in PBS. After fixation cell pellets were treated for 1 h
in 1% (w/v) osmium tetroxide, dehydrated through a series
of graded ethanols and embedded in Epon-Araldite as des-
cribed by Ormerod et al. (1994). Sections of 1 pm were then
cut, dried onto a glass slide and stained with 1% (w/v)
toluidine blue in 1% (v/v) borax before visualisation by light
microscopy. To determine DNA degradation, cells were har-
vested from both the supernatant growth medium and cell
monolayer, and genomic DNA prepared (Catchpoole and
Stewart, 1993). The internucleosomal fragmentation of DNA
obtained was assessed by the presence of laddering using the
32P end-labelling method described by Rosi et al. (1992).
Flow cytometry was used to record DNA histograms pro-
duced by cells fixed with 70% ethanol (v/v) and stained with
propidium iodide (Ormerod et al., 1992).
Results
Isolation ofvariant cell lines
The transforming potential of neu-T expression was assessed
by transfection of pSV2neu-T, together with pSV2hyg, into
the non-transformed immortalised human mammary luminal
epithelial cell line, HB4a. After a period of drug selection
lasting 2 weeks, drug-resistant clones were picked at random
and screened by indirect immunofluorescence. neu-T expres-
sion was detected in two out of four clones screened in this
manner. These two neu-T-expressing clones, N4.1 and N4.2,
were grown on and established as variant cell lines. Both the
cell lines exhibited morphological characteristics typical of
transformed cells, notably the loss of the regular epithelial
organisation seen in the hygromycin B-resistant control cell
line (H4.1) established by a similar protocol from cells trans-
fected with pSV2hyg only. The alteration of cellular morpho-
logy was most marked in the N4.1 cell line (Figure 1).*t Tyrosinekinase-induced apoptosis
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Figure 2 Expression and activation of neu-T in HB4a-derived
cell lines. c-neu was immunoprecipitated from HB4a-derived cell
lines as described. Immunocomplexes were run on SDS-PAGE,
Western blotted and probed for either c-neu [lanes 1-4 (anti-c-
neu)] or phosphotyrosine [lanes 5-8 (anti-P-Tyr)].
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Figure I Changes in cellular morphology induced by expression
of neu-T. Phase-contrast micrographs of the H4.1 (a) and N4.1
(b) cell lines derived from the non-transformed immortalised
human mammary luminal epithelial cell line, HB4a.
Bar= l00 im.
Expression ofneu-T in HB4a and variant cell lines
Southern and Northern transfer hybridisations confirmed
that the N4.1 and N4.2 cell lines had integrated the neu-T
sequence (approximately 5-10 copies) into their chromo-
somal DNA and expressed neu-T mRNA (data not shown).
Immunoprecipitation experiments showed that the neu-T pro-
tein expressed in these cell lines was phosphorylated on
tyrosine residues, indicating that, as expected, the protein is
constitutively kinase active (Figure 2). FACS analysis of live
cells showed expression of neu-T in the N4.1 and N4.2 cell
lines at the cell surface. Using the same method, the H4.1 cell
line gave a mean FACS channel value approximately equal
to that seen with a control sample, where the c-neu-specific
first antibody (NFA) had been omitted, confirming that this
human cell line does not react with the antibody against
rodent c-neu, while both neu-T-expressing variant cell lines
showed elevated values. The mean FACS channel values
were: NFA = 34, H4.1 = 37, N4.1 = 191, N4.2 = 131 on an
arithmetic (non-log) scale. Owing to its higher levels of neu-T
expression, N4.1 was selected for further detailed charac-
terisation.
Effect ofneu-T expression on cell growth and tumorigenicity
The growth characteristics of the N4.1 cell line were initially
studied using single-point growth experiments over a fixed
time period of 7 days (Figure 3). These experiments showed
that in complete growth medium the N4.1 cell line grew
faster and reached much higher cell densities than the H4.1
cell line, indicating a loss of contact inhibition of growth.
Similar experiments performed in basal medium (i.e. without
hydrocortisone, insulin and cholera toxin) revealed that the
N4.1 cell line continued to proliferate to confluence, while
the H4.1 cell line (like the parental HB4a cell line) arrested
before this point, indicating that the N4.1 cell line had
acquired reduced growth factor dependency. Proliferation
rates were examined by multipoint growth curves from which
the doubling times in the exponential growth phase were
calculated. In complete growth medium, the N4.1 cell line
was found to have a much shorter doubling time (36 h) than
the H4.1 cell line (68 h), the latter being very similar to the
parental HB4a cell line. Further examination of the reduction
in growth factor dependency of the N4.1 cell line showed
that, while the addition of hydrocortisone and insulin to
growth medium acted synergistically in the promotion of
proliferation and overgrowth, the presence of cholera toxin
reduced both the proliferative rate and the final cell density.
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Figure 3 Alterations in growth characteristics induced by expres-
sion of neu-T. Bar charts show the results of single-point cell
number determinations performed in quadruplicate (error bars
represent mean ± s.d.) on the H4.1 and N4.1 cell lines after 7
days in culture. Cells were cultured in RPMI-1640 with 10% (v/v)
fetal calf serum ( , basal), containing either hydrocortisone
and insulin alone (0, HC & I), or with cholera toxin in addition
(1, complete).
In contrast, cholera toxin stimulated the proliferation of the
H4.1 control cell line, again like the parental stocks of HB4a
(Figure 3). These changes in growth characteristics were also
observed, but to a lesser extent, in the N4.2 cell line, which
expressed lower levels of neu-T on the cell membrane (see
above).
The N4.1 cell line displayed altered growth properties in
vitro compared with the control cell line which had under-
gone a similar process of selection, isolation and expansion,
which indicated that neu-T expression had resulted in trans-
formation of the cells. This was tested further by analysing
anchorage-independent growth and growth as xenografts.
While the H4.1 cell line gave colonies in soft agar at only
very low efficiency (0.15% ± 0.08 s.d.), the N4.1 cell line
produced colonies with a diameter greater than 0.5 mm at
almost 100-fold higher efficiency (12.16% ± 1.81 s.d.). How-
ever, when assayed for tumorigenic transformation in vivo, by
subcutaneous injection into either nude or SCID mice,
neither the H4.1 cell line nor the N4.1 cell line produced
tumours in 20 animals inoculated (15 nudes and five SCIDs).
Induction ofapoptosis by serum withdrawal in cells
transformed by neu-T expression and its abrogation by
glucocorticoids
Since, when cultured in serum-containing medium, the N4.1
cell line clearly showed reduced requirements for exogenous
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growth factors, the effects of reduced serum concentrations
were examined. In low-serum medium (LSM; RPMI-1640
medium containing 0.2% (v/v) fetal calf serum) the H4.1 cell
line entered growth arrest (this was proved to be quiescence
since addition of complete medium to H4.1 cells arrested
with LSM caused them to recommence growth: data not
shown), while the N4.1 cell line underwent extensive cell
death. This showed all the hallmarks of apoptosis: loss of
cell-cell contact, membrane blebbing, cytoplasmic condensa-
tion, and eventually cell fragmentation, resulting in the
presence of a large number of small, membrane-bounded
apoptotic bodies in the supernatant medium (Figure 4a and
b). These supernatants were collected, and examination of
the fixed cells by high-resolution light microscopy revealed
that the chromatin they contained had become marginalised
and condensed (Figure 4d). Apoptosis of the N4.1 cell line
was evident after 3 days in LSM. By contrast, the super-
natant fraction obtained from the H4.1 cell line under the
same conditions was much smaller and contained only cell
debris which showed no obvious signs of apoptosis (Figure
4c).
To examine the time course of apoptosis, the effects of
serum withdrawal on the N4.1 cell line were investigated
further by measuring the condensation of the chromatin
associated with apoptosis. Samples were taken, at daily inter-
vals, from cultures of the H4.1 and N4.1 cell lines that had
been maintained in LSM, and the DNA content of these cells
was analysed by flow cytometry after staining with pro-
pidium iodide (Figure 5). On day 1 of the experiment, both
the H4.1 and the N4.1 cell lines produced DNA histograms
containing the expected GI, S-phase and G2/M populations.
By day 5, the H4.1 cell line showed a reduction in both
S-phase (from 33% to 0% of the total cell population) and
G2 (from 26% to 10%) populations, indicating G1 arrest. The
N4.1 cell line continued to show an S-phase fraction (albeit
reduced from 17% to 4% of the total cell population) with a
reduced G2 population (from 33% to 5%) and the
appearance of a sub-GI peak (14%), which has been observ-
ed in other examples of apoptosis (Ormerod et al., 1992).
Another parameter associated with apoptotic cell death is
the internucleosomal cleavage of DNA. The H4.1 and the
N4.1 cell lines were, therefore, compared using a sensitive
radiolabelling method. Cell lines were cultured in LSM and
again sampled at daily intervals. Substantial internucleosomal
fragmentation was evident in the N4.1 cells sampled from
day 3 onwards, while in contrast, even after 5 days, little or
H4.1
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Figure 5 Effects of serum withdrawal on cell cycle progression.
DNA histograms are shown from cells of the H4.1 and N4.1 cell
lines cultured in RPMI-1640 containing 0.2% (v/v) fetal calf
serum for 1, 3 and 5 days. DNA content of cells was measured
by staining DNA with propidium iodide (PI) and using flow
cytometry to quantitate the PI-DNA fluorescence.
Figure 4 Morphological changes during apoptotic cell death induced by serum withdrawal. Phase-contrast micrographs of H4.1
(a) and N4.1 (b) cell lines (bar = 100jm) after 3 days in RPMI-1640 containing 0.2% (v/v) fetal calf serum. c and d show light
micrographs of glutaraldehyde-fixed non-adherent cells from corresponding cultures (bar = 20jim).
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no such specific cleavage of DNA was seen in the H4.1 cell
line (Figure 6).
To ascertain whether exogenous growth factors were cap-
able of preventing apoptosis, a series of multiwell experi-
ments were performed, in which the adherent cells and hence
the amount of proliferation or apoptosis was assessed by
fixing and staining cells with methylene blue. This protocol
was used to study the effects of a wide range of peptide
growth factors and hormones added to LSM. These included
insulin, epidermal growth factor (EGF), nerve growth factor
(NGF), acidic fibroblast growth factor (a-FGF), basic fibro-
blast growth factor (b-FGF), transforming growth factor
alpha (TGF-x) and transforming growth factor beta (TGF-P)
(all tested in replicate at a range of concentrations between
100 and 0.01 tg ml-) as well as hydrocortisone, dexametha-
sone, corticosterone, aldosterone, deoxycorticosterone, oes-
trone, oestradiol, progesterone, testosterone, androstenedione
and dehydroepiandrosterone (all initially tested at a concen-
tration of 3 tiM). Only hydrocortisone and other steroids with
glucocorticoid activity (e.g. dexamethasone, corticosterone
and, to a lesser extent, aldosterone) were found to inhibit the
induction of apoptosis and promote proliferation of the N4.1
cell line. The oestrogens, androgens and their precursors were
all inactive, as was progesterone. A dose-response study
using hydrocortisone showed that this anti-apoptotic effect
could be produced by concentrations equivalent to those seen
physiologically (20- 100 ng ml-') (Figure 7).
Discussion
The initial aim of this present study was to define further the
role of c-erbB-2 in the progression of malignancy in human
breast tumours. neu-T, the mutated, constitutively active rat
homologue of c-erbB-2, was expressed in the conditionally
immortalised human mammary luminal epithelial cell line,
HB4a, to enable comparisons to be made with other forms of
the receptor. Expression of neu-T was found to cause altera-
tions in cellular morphology and growth characteristics in
variant cell lines found to express detectable surface p185neu-T.
In one such variant, N4.1, these changes included an increase
in proliferative rate, an increase in saturation density, a
reduction in growth factor requirements, the acquisition of
anchorage-independent growth and an altered response to
cholera toxin as seen in other transformed cells (Pastan and
Willingham, 1978). However, neither the N4.1 cell line nor a
variant of the HB4a cell line transformed with point mutated
c-Ha-ras (R4.2) (data not shown) produced tumours in nude
mice. This failure to acquire a fully malignant phenotype in
vivo has also been observed in studies with these oncogenes
using the spontaneously immortalised, non-transformed
human mammary epithelial cell line, MCF-1OA (Ciardellio et
al., 1992; Normanno et al., 1994). This is in contrast to with
the findings of D'souza et al. (1993), and shows that the role
of c-erbB-2 overexpression (or mutationally activated neu-T)
in the acquisition of tumorigenicity in human mammary
epithelial cells is as yet unresolved. However, an unexpected
observation was that the neu-T-expressing cell lines under-
went a marked apoptotic response when serum levels were
reduced to 0.2% (v/v) in another transformation assay.
Apoptosis, or programmed cell death, is a mode of physio-
logical cell death characterised by the condensation of
chromatin around the nuclear periphery and the cleavage of
DNA into oligonucleosome-size fragments by an endogenous
endonuclease. During apoptosis, cells exhibit extensive blebb-
ing of the plasma membrane accompanied by nuclear and
cytoplasmic budding to produce dense, membrane-bounded
apoptotic bodies (Kerr et al., 1972; Arends and Wyllie, 1991).
Many of the genetic alterations commonly associated with
malignancy have been shown to affect apoptosis. For exam-
ple, deregulated expression of the c-myc protooncogene
accelerates apoptosis in cells that are deprived of serum or
growth factors (Evan et al., 1992), while expression of the
gene bcl-2 or mutated forms of the tumour suppressor p53
can inhibit apoptosis (Wagner et al., 1993; Yonish-Rouach
Figure 6 Induction of internucleosomal fragmentation of DNA
by serum withdrawal. Electrophoresis of 32P end-labelled DNA
obtained from both adherent and non-adherent cells of the H4.1
(lane 1) and N4.1 (lane 7) cell lines cultured in RPMI-1640
containing either 10% (v/v) fetal calf serum (lanes 1 and 7) or
0.2% (v/v) fetal calf serum (H4.1, lanes 2-6 and N4.1, lanes
8-12), representing days 0-5 of serum deprivation. The figure
shows a negative of the autoradiograph produced.
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Figure 7 Inhibition of the induction of apoptosis by hydrocor-
tisone. Hydrocortisone concentration curves are shown for the
H4.1 (D) and N4.1 (0) cell lines after 7 days culture in RPMI-
1640 containing 0.2% (v/v) fetal calf serum supplemented with
varying concentrations of hydrocortisone. Cell survival and pro-
liferation were determined by staining cells with methylene blue
and measuring the absorbence at 620 nm in triplicate wells (error
bars represent mean ± s.d.).
et al., 1993). Apoptosis also occurs naturally during involu-
tion of the lactating rodent mammary gland following wean-
ing (Walker et al., 1989) and in the human breast epithelium
during the menstrual cycle (Anderson et al., 1982). However,
no specific mechanisms that induce or inhibit apoptosis in the
normal mammary gland have yet been identified, although
studies with the MCF-7 cell line have indicated that oest-
rogen withdrawal may promote apoptosis in xenografts of
some stocks of this cell line (Kyprianou et al., 1991). Apop-
totic cell death was not observed in vitro with this cell line. In
the present study the N4.1 cell line was found to undergo
rapid and extensive apoptotic cell death when deprived of
serum in culture. Although the induction of apoptosis by
serum withdrawal has been described for fibroblast cell lines
transformed by proto-oncogene expression (Evan et al.,
1992), a link between receptor protein tyrosine kinases and
apoptosis in epithelial cells has not previously been
reported.
The N4.1 cell line has an increased growth rate in serum-
containing medium when compared with a control cell line
cn _ATyrosine kinase-induced apoptosis
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(H4.1). This is consistent with the model that expression of
neu-T promotes entry into the cell cycle by constitutively
activating mitogenic signalling pathways. The removal of
serum growth factors signals growth arrest, and it is con-
ceivable that it is the reception of these two incompatible
growth-regulatory signals that causes the N4.1 cell line to
undergo apoptosis upon serum withdrawal. This 'conflict
hypothesis' was put forward by Evan et al. (1992) to explain
a similar response seen with Rat-I fibroblasts transformed by
c-myc. Recently, the 'conffict hypothesis' for the induction of
apoptotic cell death has been taken further (Evan and Little-
wood, 1994) to produce the 'dual hypothesis', which implies
that a protein may have dual function, performing either a
proliferative or apoptotic role depending on the cellular
environment. Thus, in the present study, the expression of
neu-T produces proliferation in the presence of serum, while
in the absence of serum it results in apoptosis. These studies
indicate that the expression of neu-T can have a dual func-
tion, and provides additional evidence that, although as yet
ill-defined, the signalling pathways for cellular proliferation,
differentiation and death are linked (Yonish-Rouach et al.,
1993). Since neu-T is known to act upstream of c-Ha-ras in
the mitogenic signal transduction pathway (Ben-Levy et al.,
1994), the observation that a variant of the HB4a cell line
R4.2 transformed by point mutated c-Ha-ras does not appear
to undergo apoptosis in low-serum medium (data not shown)
suggests that the apoptotic signalling pathway in this system
is not dependent on activation of c-Ha-ras.
The capacity to undergo apoptosis may have contributed
to the failure of the N4.1 cell line to produce tumours in
nude mice, and indicates that, to progress to a fully malig-
nant phenotype in vivo, additional genetic alterations are
necessary. One mutational event commonly found in a wide
range of human malignancies, including breast cancer, is the
inactivation of the tumour suppressor p53 (Hollstein et al.,
1991). p53 has been implicated in apoptotic cell death
(Yonish-Rouach et al., 1991). However, since p53 function is
known to be impaired by the presence of the SV40 large T
antigen (Segawa et al., 1993), which is present and active in
the HB4a cell line under the conditions used in this study, it
is likely that the serum withdrawal-induced apoptosis obser-
ved in the N4.1 cell line occurs in a p53-independent manner.
Previous studies, using fibroblast and haemopoietic cell
lines, have shown that growth factors such as insulin-like
growth factor I (IGF-I) (Harrington et al., 1994) and colony-
stimulating factors (CSFs) (Williams et al., 1990), respec-
tively, are effective in inhibiting apoptosis. However, in the
current study, the ability to prevent apoptosis induced by
serum withdrawal in the epithelially derived N4.1 cell line
was found only with glucocorticoids. Glucocorticoids have
been shown to increase the stability of c-erbB-2 mRNA
transcripts and strongly stimulate the expression of the
epidermal growth factor receptor (c-erbB-l) (Ewing et al.,
1989; Karlan et al., 1994). It is possible that, by stabilising
and increasing the expression of erbB family members, gluco-
corticoids enhance the mitogenic signals produced, even in
conditions in which ligands are limiting, such as those
experienced during serum withdrawal. Added EGF, however,
did not by itself abrogate apoptosis in this system. This
glucocorticoid abrogation of epithelial apoptotic cell death
stands in marked contrast to its role in inducing thymocyte
programmed cell death (Wyllie, 1980) but is in accordance
with the finding that glucocorticoids inhibit the apoptotic cell
death involved in the involution of the mouse mammary
gland (Ossowski et al., 1979).
Although expression of neu-T does not directly mimic the
overexpression of c-erbB-2 observed in many breast tumours,
the N4.1 cell line described above does provide a reproduci-
ble model linking receptor protein tyrosine kinases to in vitro
transformation and the induction of apoptosis in human
mammary luminal epithelial cells. A fuller understanding of
the signalling pathways involved in apoptotic cell death in
such cells might enable future drugs to be designed
specifically to activate these pathways since many current
therapeutic agents have been shown to cause cell death by
apoptosis (Hickman, 1992).
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